Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KLA CORP Director's Dealing 2019

Nov 7, 2019

29827_dirs_2019-11-07_409faae1-2f74-42f8-8806-3b0feb86f3f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KLA CORP (KLAC)
CIK: 0000319201
Period of Report: 2019-11-05

Reporting Person: KENNEDY KEVIN (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-05 Common Stock - Restricted Stock Units M 2072 Disposed 0 Direct
2019-11-05 Common Stock M 2072 Acquired 3974 Direct
2019-11-05 Common Stock - Restricted Stock Units A 1162 Acquired 1162 Direct
2019-11-05 Common Stock S 628 $174.315 Disposed 16557 Indirect
2019-11-05 Common Stock S 1472 $172.224 Disposed 15085 Indirect
2019-11-05 Common Stock S 400 $173.01 Disposed 14685 Indirect

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of KLA common stock.

F2: On November 7, 2018, the reporting person received an automatic grant of RSUs for 2,072 shares of KLA common stock. On November 5, 2019, the RSUs vested in full.

F3: On November 5, 2019, the reporting person received an automatic grant of RSUs for 1,162 shares. The RSUs vest upon the earliest to occur of (i) November 5, 2020, (ii) immediately prior to the next annual meeting of stockholders and (iii) ten days prior to a change of control.

F4: This sale was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2019.

F5: Represents the weighted average sales price for the shares. The sales prices ranged from $174.17 to $174.68. The reporting person will provide upon request full information regarding the number of shares sold at each separate price.

F6: Shares held by the Kennedy Family Trust U/A/D 11/19/98, of which the Reporting Person is a trustee and beneficiary.

F7: Represents the weighted average sales price for the shares. The sales prices ranged from $171.71 to $171.70. The reporting person will provide upon request full information regarding the number of shares sold at each separate price.

F8: Represents the weighted average sales price for the shares. The sales prices ranged from $172.83 to $173.26. The reporting person will provide upon request full information regarding the number of shares sold at each separate price.